Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (110)

Search Parameters:
Keywords = bacterial superinfection

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
25 pages, 1428 KiB  
Article
Incidence and Risk Factors of Secondary Infections in Critically Ill SARS-CoV-2 Patients: A Retrospective Study in an Intensive Care Unit
by Mircea Stoian, Leonard Azamfirei, Adina Andone, Anca-Meda Văsieșiu, Andrei Stîngaciu, Adina Huțanu, Sergio Rareș Bândilă, Daniela Dobru, Andrei Manea and Adina Stoian
Biomedicines 2025, 13(6), 1333; https://doi.org/10.3390/biomedicines13061333 - 29 May 2025
Viewed by 647
Abstract
Background/Objectives: The clinical forms of coronavirus disease 2019 (COVID-19) vary widely in severity, ranging from asymptomatic or moderate cases to severe pneumonia that can lead to acute respiratory failure, acute respiratory distress syndrome, multiple organ dysfunction syndrome, and death. Our main objective [...] Read more.
Background/Objectives: The clinical forms of coronavirus disease 2019 (COVID-19) vary widely in severity, ranging from asymptomatic or moderate cases to severe pneumonia that can lead to acute respiratory failure, acute respiratory distress syndrome, multiple organ dysfunction syndrome, and death. Our main objective was to determine the prevalence of bacterial and fungal secondary infections in an intensive care unit (ICU). Secondary objectives included analyzing the impact of these infections on mortality and medical resource utilization, as well as assessing antimicrobial resistance in this context. Methods: We conducted a retrospective cohort study that included critically ill severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients treated in an ICU and analyzed the prevalence of co-infections and superinfections. Results: A multivariate analysis of mortality found that the presence of superinfections increased the odds of death by more than 15-fold, while the Sequential Organ Failure Assessment (SOFA) score and C-reactive protein (adjusted for confounders) increased the odds of mortality by 51% and 13%, respectively. The antibiotic resistance profile of microorganisms indicated a high prevalence of resistant strains. Carbapenems, glycopeptides, and oxazolidinones were the most frequently used classes of antibiotics. Among patients, 27.9% received a single antibiotic, 47.5% received two from different classes, and 24.4% were treated with three or more. Conclusions: The incidence and spectrum of bacterial and fungal superinfections are higher in critically ill ICU patients, leading to worse outcomes in COVID-19 cases. Multidrug-resistant pathogens present significant challenges for ICU and public health settings. Early screening, accurate diagnosis, and minimal use of invasive devices are essential to reduce risks and improve patient outcomes. Full article
Show Figures

Figure 1

13 pages, 939 KiB  
Article
The Efficacy and Tolerability of Colistin Versus Non-Colistin Antimicrobial Regimens Among Hospitalized COVID-19 Patients with Multidrug-Resistant Bacterial Superinfection: An Observational Multicenter Study
by Alzahraa M. Fahmy, Marwa O. Elgendy, Alaa Aboud Mohamed, Mohamed S. Imam, Abdullah Nasser Alharbi, Muhammad Husayn Al-Anezi, Omar Mana Aldhafeeri, Saif Mamdouh Aldhafeeri, Jawaher A. Ajeebi, Marwa Kamal and Hasnaa Osama
Medicina 2025, 61(5), 884; https://doi.org/10.3390/medicina61050884 - 13 May 2025
Viewed by 649
Abstract
Background and Objectives: Bacterial infections amongst COVID-19 patients could be associated with worsened outcomes. This study aimed to investigate the efficacy of colistin antibiotic in multidrug-resistant (MDR) Gram-negative (-ve) secondary bacterial infections among hospitalized COVID-19 patients. Materials and Methods: In this [...] Read more.
Background and Objectives: Bacterial infections amongst COVID-19 patients could be associated with worsened outcomes. This study aimed to investigate the efficacy of colistin antibiotic in multidrug-resistant (MDR) Gram-negative (-ve) secondary bacterial infections among hospitalized COVID-19 patients. Materials and Methods: In this multicentered retrospective study, we analyzed data from the medical records of 116 patients diagnosed with COVID-19 infection and secondary Gram-negative MDR bacterial respiratory infections. Results: We compared those assigned to colistin versus non-colistin-based antimicrobial therapy. The two arms of the study were similar in baseline clinical features, demographics, and Gram-negative pathogens’ distribution. Acinetobacter baumannii (51.7%) was the major pathogen, followed by Klebsiella pneumonia (26.7%). Patients who received colistin-based antimicrobial regimen showed a non-significant difference compared to non-colistin antimicrobial (NCA) therapy (p > 0.05) in the main outcomes. Nephrotoxicity was significantly higher in the IV colistin group, compared to the control (34.1% and 15.3%, p = 0.018). There were substantial differences observed in the levels of serum creatinine and urea among the study arms (p = 0.029 and <0.001, respectively). Conclusions: The combination of colistin with other antimicrobial agents showed comparable results to that of NCA regimens in hospitalized COVID-19 patients with superinfections with multidrug-resistant bacterial isolates; however, there was a notably elevated incidence of nephrotoxicity with colistin antimicrobial therapy. Further randomized controlled trials are needed to assess the therapeutic benefits and tolerability of colistin antimicrobial therapy. Full article
Show Figures

Figure 1

14 pages, 775 KiB  
Article
Bacterial Superinfections After SARS-CoV-2 Pneumonia: Antimicrobial Resistance Patterns, Impact on Inflammatory Profiles, Severity Scores, and Clinical Outcomes
by Petrinela Daliu, Iulia Bogdan, Ovidiu Rosca, Alexandra Laura Aelenei, Ioan Sîrbu, Mihai Calin Bica, Monica Licker, Elena Hogea and Delia Muntean
Diseases 2025, 13(5), 145; https://doi.org/10.3390/diseases13050145 - 9 May 2025
Viewed by 638
Abstract
Background and Objectives: Secondary bacterial pneumonia can substantially worsen the clinical trajectory of patients hospitalized for Coronavirus Disease 2019 (COVID-19). This study aimed to characterize bacterial superinfections in COVID-19, including pathogen profiles, resistance patterns, inflammatory responses, severity scores, and ICU admission risk. Methods: [...] Read more.
Background and Objectives: Secondary bacterial pneumonia can substantially worsen the clinical trajectory of patients hospitalized for Coronavirus Disease 2019 (COVID-19). This study aimed to characterize bacterial superinfections in COVID-19, including pathogen profiles, resistance patterns, inflammatory responses, severity scores, and ICU admission risk. Methods: In a retrospective cohort design, we reviewed 141 patients admitted to a single tertiary-care hospital between February 2021 and December 2024. A total of 58 patients had laboratory-confirmed bacterial superinfection by sputum, bronchoalveolar lavage, or blood cultures (superinfection group), whereas 83 had COVID-19 without any documented bacterial pathogens (COVID-only group). We collected detailed microbiological data from sputum, bronchoalveolar lavage (BAL), and blood cultures. Antibiotic sensitivity testing was performed using standard breakpoints for multidrug resistance (MDR). Inflammatory markers (C-reactive protein, procalcitonin, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index) and the severity indices Acute Physiology and Chronic Health Evaluation (APACHE) II, Confusion, Urea, Respiratory rate, Blood pressure (CURB), and National Early Warning Score (NEWS) were measured at admission. Primary outcomes included intensive care unit (ICU) admission, mechanical ventilation, and mortality. Results: Patients in the superinfection group showed significantly elevated inflammatory markers and severity scores compared to the COVID-only group (mean APACHE II of 17.2 vs. 13.8; p < 0.001). Pathogens most frequently isolated from sputum and BAL included Klebsiella pneumoniae (27.6%) and Pseudomonas aeruginosa (20.7%). Multidrug-resistant strains were documented in 32.8% of isolates. The superinfection group had higher ICU admissions (37.9% vs. 19.3%; p = 0.01) and more frequent mechanical ventilation (25.9% vs. 9.6%; p = 0.01). Mortality trended higher among superinfected patients (15.5% vs. 7.2%; p = 0.09). A total of 34% of the cohort had prior antibiotic use, which independently predicted MDR (aOR 2.6, p = 0.01). The presence of MDR pathogens such as Klebsiella pneumoniae (OR 2.8), Pseudomonas aeruginosa (OR 2.5), and Staphylococcus aureus (OR 2.1) significantly increases the risk of ICU admission. Conclusions: Bacterial superinfection exacerbates inflammation and worsens outcomes in COVID-19 patients, such as a higher risk of ICU admission. Full article
Show Figures

Figure 1

11 pages, 580 KiB  
Article
Analyzing Clinical Parameters and Bacterial Profiles to Uncover the COPD Exacerbations: A Focus on Intensive Care Unit Challenges
by Dragoș Huțanu, Hédi-Katalin Sárközi, Mara Andreea Vultur, Adrian-Horațiu Sabău, Iuliu Gabriel Cocuz, Corina Mărginean, Andra-Maria Chelemen and Corina Eugenia Budin
Medicina 2025, 61(4), 669; https://doi.org/10.3390/medicina61040669 - 5 Apr 2025
Viewed by 679
Abstract
Background and Objectives: Chronic obstructive pulmonary disease (COPD) poses a significant healthcare challenge worldwide, frequently leading to exacerbations necessitating intensive care unit admissions for potentially life-threatening complications. We aimed to investigate correlations between laboratory parameters, bacteriological agents, ventilation mode, and survival rates among [...] Read more.
Background and Objectives: Chronic obstructive pulmonary disease (COPD) poses a significant healthcare challenge worldwide, frequently leading to exacerbations necessitating intensive care unit admissions for potentially life-threatening complications. We aimed to investigate correlations between laboratory parameters, bacteriological agents, ventilation mode, and survival rates among COPD patients admitted to the ICU. Materials and Methods: Data were collected from the Pulmonology Department of Mures Clinical County Hospital, Romania, from 1 January 2022 to 30 October 2023. Eighty-four COPD patients required ICU transfer, except for concurrent SARS-CoV-2 infections. Results: Ventilation modes exhibited a significant correlation with specific bacteriological agents, orotracheal intubation being more prevalent in infections with Acinetobacter baumanii, Staphylococcus aureus, and Streptococcus pneumoniae (p < 0.001). Negative cultures were predominantly found in patients managed with non-invasive ventilation. Laboratory parameters revealed an association between elevated white blood cell counts and bacteriological superinfection, particularly with Escherichia coli (p < 0.001). Different bacteriological agents had different survival rates. Patients infected with Acinetobacter baumanii exhibited the highest mortality rate, while those with Staphylococcus aureus had the lowest (p < 0.01). Conclusions: The importance of prompt evaluation of laboratory parameters and bacteriological findings is underscored by these findings, particularly in ICU settings where ventilation and bacteriological profiles influence patient outcomes. The identification of elevated WBC counts is a marker of bacterial superinfection. The association between specific bacterial agents and ventilation modes highlights the importance of tailored treatment based on microbial profiles. These insights can be applied to refine treatment protocols and enhance survival rates in severe COPD exacerbations that require ICU management. Full article
(This article belongs to the Special Issue Personalized Medicine for Patients with Respiratory Disease)
Show Figures

Figure 1

12 pages, 8617 KiB  
Article
Microbial Interactions in Nature: The Impact of Gram-Negative Bacilli on the Hyphal Growth of Candida albicans
by Madalina Adriana Bordea, Benjamin Thomas Georg Nutz, Alin-Dan Chiorean, Gabriel Samasca, Iulia Lupan, Laura Mihaela Simon and Lia Pepelea
Pathogens 2025, 14(4), 327; https://doi.org/10.3390/pathogens14040327 - 28 Mar 2025
Viewed by 708
Abstract
The escalating global prevalence of fungal and bacterial co-infections underscores the significant and multifaceted impact of ubiquitous microorganisms on both environmental equilibria and human well-being. The human microbiome, a complex ecosystem of bacterial communities, harbors opportunistic pathogens capable of inducing superinfections or concurrent [...] Read more.
The escalating global prevalence of fungal and bacterial co-infections underscores the significant and multifaceted impact of ubiquitous microorganisms on both environmental equilibria and human well-being. The human microbiome, a complex ecosystem of bacterial communities, harbors opportunistic pathogens capable of inducing superinfections or concurrent infections with Candida spp. The intricate interplay, exemplified by the interaction between Candida albicans and diverse bacteria, necessitates rigorous investigation to elucidate mechanisms by which this polymicrobial behavior potentiates fungal virulence, particularly in immunocompromised individuals. Our study aims to comprehensively examine the ramifications of these interactions, with a specific focus on their influence on fungal virulence and the consequent exacerbation of disease severity. Achieving a comprehensive understanding of these complex relationships is paramount for informing effective clinical management strategies for infectious diseases, and the accurate identification of fungal–bacterial co-infections holds substantial implications for optimizing clinical treatment paradigms, especially in vulnerable immunocompromised hosts. Full article
(This article belongs to the Section Bacterial Pathogens)
Show Figures

Figure 1

16 pages, 1638 KiB  
Article
Elevated Serum Presepsin Identifies Herpes Simplex Virus-1 Reactivation in COVID-19 Patients
by Patricia Mester, Dennis Keller, Claudia Kunst, Stephan Schmid, Sabrina Krautbauer, Martina Müller, Christa Buechler and Vlad Pavel
Viruses 2025, 17(3), 357; https://doi.org/10.3390/v17030357 - 28 Feb 2025
Viewed by 756
Abstract
Presepsin, a cleaved peptide of soluble CD14, may become a promising biomarker for assessing disease severity and mortality in coronavirus disease 2019 (COVID-19). Patients with severe COVID-19 frequently develop bacterial and fungal superinfections, as well as herpes simplex virus-1 (HSV-1) reactivation, which may [...] Read more.
Presepsin, a cleaved peptide of soluble CD14, may become a promising biomarker for assessing disease severity and mortality in coronavirus disease 2019 (COVID-19). Patients with severe COVID-19 frequently develop bacterial and fungal superinfections, as well as herpes simplex virus-1 (HSV-1) reactivation, which may exacerbate disease progression. This study aimed to evaluate the impact of concomitant infections on serum presepsin levels. Serum presepsin levels were measured using an enzyme-linked immunosorbent assay (ELISA) in 63 patients with moderate COVID-19, 60 patients with severe disease, and 49 healthy controls. Correlations with procalcitonin and the presence of superinfections or HSV-1 reactivation were assessed. Consistent with previous studies, serum presepsin levels were the highest in patients with severe COVID-19 (p = 0.002 compared to patients with moderate disease). Within this group, non-survivors exhibited significantly elevated presepsin levels (p = 0.027). A positive correlation between presepsin and procalcitonin was observed in both moderate and severe COVID-19 cases. Patients with bacterial or fungal superinfections showed presepsin levels comparable to those without secondary infections. However, presepsin levels were markedly elevated in patients with HSV-1 reactivation (p = 0.002). After excluding patients with HSV-1 reactivation, presepsin levels no longer differed between moderate and severe COVID-19 cases, though they remained higher than in healthy controls (p < 0.001 for both comparisons). In conclusion, these findings suggest that elevated serum presepsin levels in severe COVID-19 are primarily driven by HSV-1 reactivation rather than bacterial or fungal superinfections. Full article
(This article belongs to the Special Issue Viral Sepsis: Pathogenesis, Diagnostics and Therapeutics)
Show Figures

Figure 1

15 pages, 278 KiB  
Article
Clinical Features and Antibiotic Susceptibility of Staphylococcus aureus-Infected Dermatoses
by Dimitra Koumaki, Sofia Maraki, Georgios Evangelou, Vasiliki Koumaki, Stamatios Gregoriou, Stamatoula Kouloumvakou, Danae Petrou, Evangelia Rovithi, Kyriaki Zografaki, Aikaterini Doxastaki, Petros Ioannou, Ioanna Gkiaouraki, Antonios Rogdakis, Viktoria Eirini Mavromanolaki and Konstantinos Krasagakis
J. Clin. Med. 2025, 14(4), 1084; https://doi.org/10.3390/jcm14041084 - 8 Feb 2025
Viewed by 1126
Abstract
Background/Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) poses significant treatment challenges, particularly in community settings. Limited data are available on S. aureus-associated infected dermatoses (ID) in outpatient dermatology clinics. This study examines the clinical characteristics, microbiological profiles, resistance patterns, and treatment outcomes of dermatoses [...] Read more.
Background/Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) poses significant treatment challenges, particularly in community settings. Limited data are available on S. aureus-associated infected dermatoses (ID) in outpatient dermatology clinics. This study examines the clinical characteristics, microbiological profiles, resistance patterns, and treatment outcomes of dermatoses caused by S. aureus. Methods: Between January 2023 and January 2025, consecutive patients with confirmed S. aureus-associated SD were recruited in a dermatology clinic in Heraklion, Greece. Demographic, clinical, and treatment data were collected. Skin swabs underwent bacterial culture and antimicrobial susceptibility testing following CLSI guidelines. Statistical analyses evaluated associations between clinical and microbiological findings. Results: Sixty-eight patients were included, 54.4% of whom were male, with a mean age of 46.7 years (± SD 25.1). MRSA was identified in 22.1% of cases and was significantly associated with female gender (p = 0.014). The most common diagnoses were eczema (35.3%) and folliculitis (19.1%). Oxacillin-resistant patients were more likely to receive systemic therapy (p = 0.039). Resistance rates were highest for benzylpenicillin (81.8%), levofloxacin (54.9%), and erythromycin (39.4%). Resistance rates for fusidic acid, clindamycin, mupirocin, and tetracycline were 38.2%, 20.6%, 16.9%, and 10.3%, respectively. Other pathogens, including Pseudomonas aeruginosa and Escherichia coli, were isolated in 27.9% of cases. Conclusions: This study highlights the high prevalence of MRSA in outpatient dermatology settings, emphasizing the need for local antimicrobial resistance surveillance to guide treatment strategies and improve outcomes in superinfected dermatoses. Full article
(This article belongs to the Section Dermatology)
11 pages, 2206 KiB  
Article
Rhipicephalus microplus and Its Impact on Anaplasma marginale Multistrain Infections in Contrasting Epidemiological Contexts
by Agustina E. Pérez, Eliana C. Guillemi, Nestor F. Sarmiento, Germán J. Cantón and Marisa D. Farber
Pathogens 2025, 14(2), 160; https://doi.org/10.3390/pathogens14020160 - 7 Feb 2025
Cited by 1 | Viewed by 1335
Abstract
Bovine anaplasmosis is a disease caused by Anaplasma marginale, a tick-borne bacterial pathogen with global distribution, primarily determined by the range of its vector. In Argentina, Rhipicephalus microplus is the main species associated with A. marginale transmission, even though this bacterium can [...] Read more.
Bovine anaplasmosis is a disease caused by Anaplasma marginale, a tick-borne bacterial pathogen with global distribution, primarily determined by the range of its vector. In Argentina, Rhipicephalus microplus is the main species associated with A. marginale transmission, even though this bacterium can also be mechanically transmitted. We studied complex infections (more than one A. marginale variant) in naturally infected bovines from two different epidemiological contexts: a region with the tick vector and a tick-free region. In the tick-free area, symptomatic infections were associated with a single A. marginale genotype, while asymptomatic bovines from the same herd remained chronically infected with a low number of genotype variants. By contrast, in the region where R. microplus is present, the only symptomatic bovine showed highly diverse infections, with 19 distinctive genotypes. Additionally, A. marginale genotypes were also detected in tick tissues. These findings, together with previous data, indicate that R. microplus harbors A. marginale populations that are maintained through tick generations by means of transovarial transmission. Furthermore, this tick species is responsible for maintaining A. marginale diversity in the bovine host over time through coinfection and superinfection events. Full article
(This article belongs to the Section Ticks)
Show Figures

Figure 1

15 pages, 839 KiB  
Review
Recent Discovery of Diverse Prophages Located in Genomes of Vibrio spp. and Their Implications for Bacterial Pathogenicity, Environmental Fitness, Genome Evolution, Food Safety, and Public Health
by Yafei Ou, Jun Yan, Yongjie Wang and Lanming Chen
Foods 2025, 14(3), 403; https://doi.org/10.3390/foods14030403 - 26 Jan 2025
Viewed by 1389
Abstract
Bacteria in the genus Vibrio, including at least 152 species, thrive in marine and estuarine environments and are frequently detected in aquatic products worldwide. Of these, 12 species have been implicated in human infectious diseases, such as the life-threatening pandemic cholera, acute [...] Read more.
Bacteria in the genus Vibrio, including at least 152 species, thrive in marine and estuarine environments and are frequently detected in aquatic products worldwide. Of these, 12 species have been implicated in human infectious diseases, such as the life-threatening pandemic cholera, acute gastroenteritis, and severe sepsis. Nevertheless, molecular mechanisms of their pathogenesis are not fully uncovered yet. Prophages are found prevalent in Vibrio spp. genomes, carrying a number of genes with various functions. In this review, we deciphered the evolutionary relationship between prophages and Vibrio species and highlighted the impact of prophages on the bacterial pathogenicity, environmental fitness, and genome evolution, based on 149 newly discovered intact prophages located in the genomes of 82 Vibrio spp., which we searched and collected from Web of Science Core Collection in the most recent 5 years. The effects of prophages on resistance to superinfection, strain competition, and their regulation were also discussed. This review underscored crucial roles of prophages in shaping Vibrio spp. genomes and their implications for food safety and public health. Full article
(This article belongs to the Section Food Quality and Safety)
Show Figures

Figure 1

15 pages, 242 KiB  
Article
Impact of Multidrug-Resistant Bacteria in a Cohort of COVID-19 Critically Ill Patients: Data from a Prospective Observational Study Conducted in a High-Antimicrobial-Resistance-Prevalence Center
by Giorgia Montrucchio, Francesca Grillo, Eleonora Balzani, Giulia Gavanna, Gabriele Sales, Chiara Bonetto, Umberto Simonetti, Marinella Zanierato, Vito Fanelli, Claudia Filippini, Silvia Corcione, Francesco Giuseppe De Rosa, Antonio Curtoni, Cristina Costa and Luca Brazzi
J. Clin. Med. 2025, 14(2), 410; https://doi.org/10.3390/jcm14020410 - 10 Jan 2025
Cited by 2 | Viewed by 1087
Abstract
Background: Bacterial superinfections are common complications during viral infections, but the impact of multidrug-resistant (MDR) pathogens in critically ill patients affected by coronavirus disease 2019 (COVID-19) is still debated. Methods: This is an observational, monocentric, and prospective study designed to investigate [...] Read more.
Background: Bacterial superinfections are common complications during viral infections, but the impact of multidrug-resistant (MDR) pathogens in critically ill patients affected by coronavirus disease 2019 (COVID-19) is still debated. Methods: This is an observational, monocentric, and prospective study designed to investigate the incidence, risk factors, and outcomes of MDR bacterial superinfections in COVID-19 patients admitted to the intensive care unit (ICU). Results: A high incidence of superinfections (66%, 159/241) was observed: ventilator-associated pneumonia (VAP) (65%, 104/159) and bloodstream infection (BSI, 32%, 51/159) were the most common. Superinfections, Extra-Corporeal Membrane Oxygenation (ECMO) support, and prone positioning increased the risk of death five, four, and more-than-two times, respectively (OR = 5.431, IC 95%: 1.637–18.014; 4.462, IC 95%: 1.616–12.324 and 2.346, IC 95%: 1.127–4.883). MDR bacteria were identified in 61% of patients with superinfection, with a cumulative incidence of 37.2% at day 14. Carbapenem-resistant Acinetobacter baumannii (CR-AB) and CR-Klebsiella pneumoniae (CR-KP) were the most common causative agents (24.3% and 13.7%). CR-AB was found to significantly increase both ICU and in-hospital mortality (76.4% and 78.2%), whereas CR-KP had no direct impact on mortality. Prior rectal colonization (p < 0.0001), mechanical ventilation (p = 0.0017), a prolonged ICU stay (p < 0.0001), the use of iNO (p = 0.0082), vasopressors (p = 0.0025), curarization (p = 0.0004), and prone positioning (p = 0.0084) were found to be risk factors for CR-AB. Conclusions: Critically ill COVID-19 patients are at high risk of developing MDR superinfection. While CR-KP had no direct impact on mortality, CR-AB appeared to increase ICU and in-hospital mortality. Full article
(This article belongs to the Section Infectious Diseases)
27 pages, 1698 KiB  
Systematic Review
Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania—A Systematic Review
by Dan Dumitru Vulcanescu, Iulia Cristina Bagiu, Cecilia Roberta Avram, Licinia Andrada Oprisoni, Sonia Tanasescu, Teodora Sorescu, Razvan Susan, Monica Susan, Virgiuliu Bogdan Sorop, Mircea Mihai Diaconu, Tiberiu Liviu Dragomir, Octavia Oana Harich, Razvan Mihai Horhat, Stefania Dinu and Florin George Horhat
Antibiotics 2024, 13(12), 1219; https://doi.org/10.3390/antibiotics13121219 - 14 Dec 2024
Cited by 3 | Viewed by 2126
Abstract
Background: The COVID-19 pandemic has intensified concerns over bacterial infections and antimicrobial resistance, particularly in Romania. This systematic review explores bacterial infection patterns and resistance during the pandemic to address critical gaps in knowledge. Methods: A systematic review, following PRISMA guidelines, was conducted [...] Read more.
Background: The COVID-19 pandemic has intensified concerns over bacterial infections and antimicrobial resistance, particularly in Romania. This systematic review explores bacterial infection patterns and resistance during the pandemic to address critical gaps in knowledge. Methods: A systematic review, following PRISMA guidelines, was conducted using databases such as PubMed and Scopus, focusing on studies of bacterial infections from 2020 to 2022. Articles on bacterial infections in Romanian patients during the pandemic were analyzed for demographic data, bacterial trends, and resistance profiles. Results: A total of 87 studies were included, detailing over 20,000 cases of bacterial infections. The review found that Gram-negative bacteria, particularly Escherichia coli and Klebsiella pneumoniae, were the most frequently identified pathogens, alongside Gram-positive Staphylococcus aureus and Enterococcus spp. Multidrug resistance (MDR) was noted in 24% of the reported strains, with common resistance to carbapenems and cephalosporins. Conclusions: The pandemic has amplified the complexity of managing bacterial infections, particularly in critically ill patients. The rise in MDR bacteria underscores the need for stringent antimicrobial stewardship and infection control measures. Continuous monitoring of bacterial trends and resistance profiles will be essential to improve treatment strategies in post-pandemic healthcare settings. Full article
Show Figures

Figure 1

17 pages, 2849 KiB  
Article
Orally Administered Lactobacilli Strains Modulate Alveolar Macrophages and Improve Protection Against Respiratory Superinfection
by Leonardo Albarracin, Stefania Dentice Maidana, Kohtaro Fukuyama, Mariano Elean, Julio Nicolás Argañaraz Aybar, Yoshihito Suda, Keita Nishiyama, Haruki Kitazawa and Julio Villena
Biomolecules 2024, 14(12), 1600; https://doi.org/10.3390/biom14121600 - 14 Dec 2024
Cited by 1 | Viewed by 1179
Abstract
Orally administered immunomodulatory lactobacilli can stimulate respiratory immunity and enhance the resistance to primary infections with bacterial and viral pathogens. However, the potential beneficial effects of immunomodulatory lactobacilli against respiratory superinfection have not been evaluated. In this work, we showed that the feeding [...] Read more.
Orally administered immunomodulatory lactobacilli can stimulate respiratory immunity and enhance the resistance to primary infections with bacterial and viral pathogens. However, the potential beneficial effects of immunomodulatory lactobacilli against respiratory superinfection have not been evaluated. In this work, we showed that the feeding of infant mice with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum MPL16 strains can reduce susceptibility to the secondary pneumococcal infection produced after the activation of TLR3 in the respiratory tract or after infection with RVS. The treatment of mice with CRL1505 or MPL16 strains by the oral route improved the production of interferons in the respiratory tract, differentially modulated the balance of pro- and anti-inflammatory cytokines, reduced bacterial replication, and diminished lung damage. Additionally, we demonstrated that orally administered lactobacilli confer longstanding protection against secondary Streptococcus pneumoniae infection and that this effect would be mediated by the stimulation of trained alveolar macrophages. This work contributes to revealing the mechanisms involved in the modulation of the gut–lung axis by beneficial microbes by demonstrating that specific lactobacilli strains, through the stimulation of the common mucosal immune system, would be able to support the development of trained alveolar macrophages that would confer longstanding protection against secondary bacterial challenges produced after a primary inflammatory event in the respiratory mucosa. Full article
(This article belongs to the Section Natural and Bio-derived Molecules)
Show Figures

Figure 1

13 pages, 10432 KiB  
Article
Management of COVID-19 Infection Associated Lung Abscess with Secondary Pleural Empyema Using Percutaneous Intracavitary Drainage: Case Series and Review of the Literature
by Emanuel Palade, Ioana-Medeea Titu, Angela Elena Goia, Tudor Dan Simu, Sergiu Adrian Ciulic, Simona Manole and Monica Mlesnite
J. Clin. Med. 2024, 13(22), 6962; https://doi.org/10.3390/jcm13226962 - 19 Nov 2024
Viewed by 2345
Abstract
Background/Objectives: COVID-19-related pulmonary complications, such as lung abscesses and pleural empyema, are rare but serious. This study presents a case series of three patients with COVID-19-associated lung abscesses complicated by pleural empyema, managed conservatively with percutaneous intracavitary drainage (ICD) and lavage. We [...] Read more.
Background/Objectives: COVID-19-related pulmonary complications, such as lung abscesses and pleural empyema, are rare but serious. This study presents a case series of three patients with COVID-19-associated lung abscesses complicated by pleural empyema, managed conservatively with percutaneous intracavitary drainage (ICD) and lavage. We assess the efficacy and safety of this treatment and compare our findings with the current literature. Methods: A retrospective analysis of three cases treated at the Clinic of Thoracic Surgery and Intensive Care Unit in Cluj-Napoca, Romania, was conducted. All patients developed severe lung involvement post-COVID-19, with abscesses rupturing into the pleural cavity. Conservative management included percutaneous ICD and daily lavage with isotonic saline, avoiding extensive surgery due to the patients’ critical condition. Clinical, radiological, and functional outcomes were followed, and results were compared to similar cases in the literature. Results: Among 496 critically ill patients with COVID-19 infection, three patients (age 42–60) developed lung abscesses and bacterial superinfection. In all patients, the germs involved were identified (monomicrobial infection in 1, polymicrobial in 2 patients). The abscesses were treated with percutaneous ICD and lavage, leading to clinical improvement in all cases. Long-term drainage (94–290 days) was necessary to obtain healing, and none of the patients required lung resection or decortication. Serial CT scans showed resolution of the abscesses and empyema. All were successfully discharged, and long-term follow-up (30–32 months) revealed minor radiological sequelae and mild respiratory impairment. The literature review found three studies summarizing 45 patients with lung abscesses complicating COVID-19 infections, but only one study addressed the use of percutaneous ICD. The mortality reported in this group was high (50–65%). Conclusions: Conservative treatment with percutaneous ICD and lavage is effective in managing lung abscesses and pleural empyema in critically ill COVID-19 patients, offering a viable alternative to surgery in high-risk cases. This method may be beneficial in multidisciplinary care for non-surgical candidates. Full article
(This article belongs to the Section Respiratory Medicine)
Show Figures

Graphical abstract

13 pages, 2191 KiB  
Case Report
Severe Bacterial Superinfection of Influenza Pneumonia in Immunocompetent Young Patients: Case Reports
by Szymon Białka, Michał Zieliński, Magdalena Latos, Marlena Skurzyńska, Michał Żak, Piotr Palaczyński and Szymon Skoczyński
J. Clin. Med. 2024, 13(19), 5665; https://doi.org/10.3390/jcm13195665 - 24 Sep 2024
Cited by 5 | Viewed by 2702
Abstract
Influenza can lead to or coexist with severe bacterial pneumonia, with the potential to permanently damage lung tissue, refractory to conservative treatment in the post-COVID-19 period. It can lead to serious complications; therefore, annual vaccinations are recommended. This case series with a literature [...] Read more.
Influenza can lead to or coexist with severe bacterial pneumonia, with the potential to permanently damage lung tissue, refractory to conservative treatment in the post-COVID-19 period. It can lead to serious complications; therefore, annual vaccinations are recommended. This case series with a literature review pertains to two young female patients with an insignificant past medical history, who required emergency lobectomy due to bacterial complications after influenza infection. Urgent lobectomy proves to be a feasible therapeutic option for selected patients with pleural complications. Full article
(This article belongs to the Special Issue Update on Acute Severe Respiratory Infections)
Show Figures

Figure 1

13 pages, 1730 KiB  
Article
Calprotectin, a Promising Serological Biomarker for the Early Diagnosis of Superinfections with Multidrug-Resistant Bacteria in Patients with COVID-19
by Dennis Keller, Patricia Mester, Ulrich Räth, Sabrina Krautbauer, Stephan Schmid, Verena Greifenberg, Martina Müller, Claudia Kunst, Christa Buechler and Vlad Pavel
Int. J. Mol. Sci. 2024, 25(17), 9294; https://doi.org/10.3390/ijms25179294 - 27 Aug 2024
Cited by 1 | Viewed by 1635
Abstract
Bacterial and fungal superinfections are common in COVID-19, and early diagnosis can enable timely intervention. Serum calprotectin levels increase with bacterial, fungal, and viral infections. This study evaluated serum calprotectin as a diagnostic and prognostic tool for microbial superinfections in COVID-19. Serum samples [...] Read more.
Bacterial and fungal superinfections are common in COVID-19, and early diagnosis can enable timely intervention. Serum calprotectin levels increase with bacterial, fungal, and viral infections. This study evaluated serum calprotectin as a diagnostic and prognostic tool for microbial superinfections in COVID-19. Serum samples from adult patients with moderate and severe COVID-19 were collected during hospitalization from 2020 to 2024. Calprotectin levels were measured using an enzyme-linked immunosorbent assay in 63 patients with moderate COVID-19, 60 patients with severe COVID-19, and 34 healthy individuals. Calprotectin serum levels were elevated in patients with moderate COVID-19 compared with controls, and these levels were further increased in the severe cases. Patients with severe COVID-19 and vancomycin-resistant enterococci (VRE) bacteremia had elevated calprotectin levels, but their C-reactive protein and procalcitonin levels were not increased. Fungal superinfections and herpes simplex virus reactivation did not change the calprotectin levels. A calprotectin concentration of 31.29 µg/mL can be used to diagnose VRE bloodstream infection with 60% sensitivity and 96% specificity. These data suggest that serum calprotectin may be a promising biomarker for the early detection of VRE bloodstream infections in patients with COVID-19. Full article
(This article belongs to the Special Issue Molecular Research and Insights into COVID-19: 2nd Edition)
Show Figures

Figure 1

Back to TopTop